Julie is a co-founder of KeepBio and its Head of Research and Development, a product developer and R&D leader with more than a decade of experience translating novel microbiome products from concept to mid-stage clinical development. She is first author on two Cell Host & Microbe papers on precision microbiome engineering with a synbiotic, the foundational research KeepBio is built on. As Director of Non-clinical Research at Prolacta Bioscience, she developed a synbiotic of B. infantis and human milk oligosaccharides, co-authored an IND that won FDA approval for a Phase 2a clinical trial, and built and led a team of seven PhD- and MS-level scientists. Prior to Prolacta, she was Head of the Discovery Lab at Solarea Bio and a senior scientist at Seres Therapeutics, contributing to two FDA-approved INDs, to the product that became VOWST™, and the product that became Bōndia™. She holds a PhD in microbiology from Yale, an A.B. in molecular biology from Princeton, and completed postdoctoral training at the Center for Systems Biology at Harvard.